Boundless Bio Inc
NASDAQ:BOLD
Cash Flow Statement
Cash Flow Statement
Boundless Bio Inc
| Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||
| Net Income |
(65)
|
(58)
|
(61)
|
(65)
|
(66)
|
(64)
|
(62)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
5
|
5
|
6
|
8
|
8
|
8
|
7
|
|
| Other Non-Cash Items |
3
|
3
|
4
|
5
|
6
|
7
|
7
|
|
| Change in Working Capital |
(2)
|
(2)
|
(1)
|
(2)
|
(1)
|
1
|
2
|
|
| Cash from Operating Activities |
(63)
N/A
|
(56)
+11%
|
(57)
-2%
|
(61)
-7%
|
(60)
+2%
|
(55)
+7%
|
(52)
+6%
|
|
| Investing Cash Flow | ||||||||
| Capital Expenditures |
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(1)
|
(1)
|
|
| Other Items |
(19)
|
(40)
|
(10)
|
(24)
|
(39)
|
39
|
27
|
|
| Cash from Investing Activities |
(20)
N/A
|
(42)
-109%
|
(12)
+71%
|
(26)
-115%
|
(41)
-58%
|
38
N/A
|
27
-30%
|
|
| Financing Cash Flow | ||||||||
| Net Issuance of Common Stock |
100
|
90
|
90
|
90
|
0
|
0
|
0
|
|
| Other |
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
97
N/A
|
88
-9%
|
88
+0%
|
90
+2%
|
91
+1%
|
0
-100%
|
0
+6%
|
|
| Change in Cash | ||||||||
| Net Change in Cash |
14
N/A
|
(10)
N/A
|
19
N/A
|
3
-85%
|
(10)
N/A
|
(17)
-66%
|
(25)
-51%
|
|
| Free Cash Flow | ||||||||
| Free Cash Flow |
(63)
N/A
|
(58)
+9%
|
(59)
-2%
|
(63)
-7%
|
(62)
+2%
|
(56)
+9%
|
(53)
+6%
|
|